HWH International Inc. HWH
Company was originally incorporated in Delaware on October 20, 2021 under the name Alset Capital Acquisition Corp. The Company was formed
for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses (the "Business Combination"). The Company consummated the Business Combination on
January 9, 2024 and changed its name from "Alset Capital Acquisition Corp." to "HWH International Inc." The Company
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $866.9K | $1.3M | $1.2K | — | — |
| Cost of revenue | $407.2K | $651.7K | $334.8K | — | — |
| Gross profit | $459.7K | $601.9K | $495.7K | — | — |
| SG&A | $3.5M | $2.8M | $2.9M | $589.6K | — |
| Total operating expenses | $3.6M | $3.2M | $3.4M | $689.6K | — |
| Interest expense | $52.2K | $72.1K | — | — | — |
| Pre-tax income | -$2.6M | -$2.8M | -$661.3K | $300.5K | — |
| Income tax | $47.5K | — | $415.4K | $186.9K | — |
| Net income | -$2.6M | -$2.7M | -$1.1M | $113.5K | — |
| EPS, basic | -0.40 | -0.76 | — | — | — |
| EPS, diluted | -0.40 | -0.76 | — | — | — |
| Shares, diluted (wtd. avg.) | 6.6M | 3.6M | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | $2.1M | $4.3M | $1.2M | $1.2M | $50.0K |
| Short-term investments | — | $13.3K | — | — | — |
| Inventory | $1.1K | $1.6K | $2.0K | — | — |
| Total current assets | $3.0M | $5.5M | $1.3M | $1.2M | $135.0K |
| Property, plant and equipment | $19.2K | $33.6K | $129.2K | — | — |
| Goodwill | $116.6K | $0 | — | — | — |
| Total assets | $4.6M | $6.4M | $23.7M | $89.3M | $135.0K |
| Accounts payable | $305.0K | $483.4K | $167.4K | $376.5K | — |
| Total current liabilities | $1.3M | $3.3M | $6.0M | $376.5K | $115.0K |
| Total liabilities | — | — | $3.9M | $3.4M | $115.0K |
| Retained earnings | -$8.9M | -$6.3M | -$3.6M | -$2.0M | -$5.0K |
| Total equity | $2.6M | $2.8M | -$3.6M | -$1.4M | $20.0K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$1.8M | -$1.8M | -$2.6M | -$514.1K | — |
| Depreciation and amortisation | $19.5K | $48.2K | $58.0K | — | — |
| Stock-based compensation | $1.6M | — | — | — | — |
| Capital expenditure | $19.5K | $30.4K | $14.6K | — | — |
| Investing cash flow | -$1.2M | $20.5M | $68.4M | -$87.1M | — |
| Financing cash flow | $934.7K | -$15.6M | -$67.5M | $88.8M | — |
| Buybacks | — | $21.1M | $68.4M | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-012738.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $1.2K | $1.3M | $866.9K |
| Gross profit | — | — | $495.7K | $601.9K | $459.7K |
| Net income | — | $113.5K | -$1.1M | -$2.7M | -$2.6M |
Recent filings and events
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Change of control Control of the company has changed hands. Item 5.01
- Officer or director change Item 5.02
- Other event Item 8.01
- Material agreement signed Item 1.01
- Unregistered share sale Item 3.02
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Material agreement signed Item 1.01
- Unregistered share sale Item 3.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 5122
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MCK | MCKESSON CORP | $116.68B | 26.1x | 12.4% |
| COR | Cencora, Inc. | $63.16B | 41.6x | 9.3% |
| CAH | CARDINAL HEALTH INC | $58.04B | 34.5x | 14.2% |
| HLF | HERBALIFE LTD. | $1.40B | 6.1x | 0.9% |
| NUS | NU SKIN ENTERPRISES, INC. | $233.2M | 1.5x | -14.3% |
| COSM | Cosmos Health Inc. | $26.3M | — | 19.9% |
| MEDS | DataMeds AI, Inc. | $6.8M | — | 28.7% |
| HKPD | Cellyan Biotechnology Co., Ltd | — | — | — |